LEIGH CORDILL: Open Payments
NPI 1528126588 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 25 payments from 8 companies in 2025. Trend: 2023 $786 · 2024 $633 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $237 |
| Organon LLC | 4 | $71 |
| ABBVIE INC. | 3 | $69 |
| Janssen Biotech, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $36 |
| UCB, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Almirall LLC | 1 | $20 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, VTAMA, TALTZ, Bimzelx, SPEVIGO, Seysara.
Industry payments across LA — which companies pay providers there.
